NXPI — Kurt Sievers Retirement as CEO of NXP Semiconductors
Oct 28, 2025, 7:00:00 AM UTC
Summary
Kurt Sievers, the CEO and executive director of NXP Semiconductors N.V., will retire on October 28, 2025. The company has appointed Rafael Sotomayor as his successor, effective the same date. Sotomayor has been with NXP's executive management team since 2020 and currently serves as the executive vice president and general manager of Secure Connected Edge. Sievers' departure is voluntary and not linked to any concerns regarding the company’s strategic or financial performance. He will remain as a strategic advisor until December 31, 2025, during the leadership transition. The transition is part of a broader succession planning effort by NXP's Board of Directors.
Company
NXP SEMICONDUCTORS NV (NXPI)NASDAQ — Technology: Manufacturing, Semiconductors: Semiconductors & Related Devices
www.nxp.comSimilar Events
Kurt Sievers Transition to Strategic Advisor at NXP Semiconductors
Kurt Sievers will transition from the role of CEO and executive director of NXP Semiconductors N.V. to serve as a strategic advisor until December 31, 2025. His resignation is not related to any performance issues and follows the Board's decision to appoint Rafael Sotomayor as the new CEO effective October 28, 2025. Sievers' current salary and benefits will continue during his advisory role, and he remains eligible for the 2025 annual incentive program bonus, contingent on performance metrics. This leadership transition coincides with NXP's ongoing strategic planning efforts to ensure stability during this period.
Operational AnnouncementDeparture of CFO Niklas Axelsson from Sprint Bioscience AB
Niklas Axelsson has announced his departure as CFO of Sprint Bioscience AB to pursue a new opportunity in another company. He will remain with Sprint during his three-month notice period while a search for his successor begins. Johan Emilsson, CEO, acknowledged Axelsson's significant contributions during his brief tenure, particularly in the recent capital raise and ongoing discussions with potential partners. Sprint Bioscience focuses on developing first-in-class small-molecule oncology therapies and has successfully entered multiple licensing agreements with global pharmaceuticals.
CFO Departure AnnouncementTermination of Charles Remsberg as Chief Sales Officer
Charles Remsberg's employment as the Chief Sales Officer of Lifeward Ltd. will be terminated effective May 30, 2025, classified as a termination without cause. In the preliminary revenue results announced on April 14, 2025, Lifeward projected approximately $5.0 million in revenue for the quarter ended March 31, 2025, against operating expenses expected between $6.5 million and $6.7 million. Remsberg's departure will see him receive severance and other benefits as per his employment agreement, which was disclosed in its recent Annual Report. The decision aligns with the company's strategic direction amid financial challenges observed in the quarterly figures.
employment terminationRetirement of Andrew J. Paul as CEO
Andrew J. Paul will retire as Chief Executive Officer of Corsair Gaming, Inc., effective July 1, 2025. His retirement, which is not due to any dispute with the company, was formally announced following his notification on February 10, 2025. Paul will serve in his role until the transition end date and will receive his base salary during this period. Thi La, currently the President and Chief Operating Officer of Corsair, has been appointed to succeed him starting on the same date. La's compensation package includes an annual salary of $800,000 and potential equity awards valued at $5 million, subject to performance metrics. This leadership transition is part of the company's strategic planning as it adjusts to future market demands.
Executive Transition